Nutrient-gene interactions in obesity prevention through personalized approaches

Introduction

The concept that dietary requirements vary among individuals based on their genetic constitution dates back to the early observations of Archibald Garrod in 1902, who first described inborn errors of metabolism [1] . However, it was not until the completion of the Human Genome Project and the subsequent explosion of genome-wide association findings that the molecular basis of gene-nutrient interactions could be systematically investigated. This historical progression has culminated in the contemporary field of nutrigenomics, which seeks to understand how nutrients and other dietary bioactives influence gene expression, and how genetic variation affects individual responses to dietary components [2] . Obesity represents one of the most pressing public health challenges of the 21st century, affecting over 650 million adults globally and contributing substantially to cardiovascular disease, type 2 diabetes, and certain cancers [3] . Despite decades of public health messaging emphasizing caloric restriction and increased physical activity, population-level obesity rates continue to rise. This apparent failure of conventional approaches has prompted reconsideration of the paradigm, with growing recognition that inter-individual variation in response to dietary interventions reflects underlying genetic heterogeneity [4] . Genome-wide association studies have identified numerous genetic variants associated with obesity susceptibility, with the FTO gene representing the most robustly replicated locus [5] . The FTO rs9939609 polymorphism confers approximately 30% increased obesity risk per risk allele, with effects mediated through altered appetite regulation and energy homeostasis. Additional variants in MC4R, PPARG, ADRB2, and LEPR contribute to the polygenic architecture of obesity, each exerting modest individual effects that accumulate to influence overall susceptibility [6] . The observation that carriers of certain genetic variants respond differently to specific dietary interventions has provided the conceptual foundation for genotype-guided nutrition counseling [7] . Several randomized trials have examined whether genetic information can improve weight loss outcomes when incorporated into dietary counseling. The Food4Me trial demonstrated that personalized nutrition advice based on phenotypic, dietary, and genetic information produced modest improvements in dietary quality compared to standard recommendations [8] . However, methodological heterogeneity across studies and inconsistent application of genetic findings to actionable dietary recommendations have limited the translation of nutrigenomic discoveries into clinical practice [9] . Singapore presents a unique context for investigating nutrient-gene interactions due to its multi-ethnic population encompassing Chinese, Malay, and Indian ancestry groups with distinct genetic backgrounds and dietary traditions [10] . The rising prevalence of obesity and associated metabolic complications in Singapore has generated substantial interest in precision approaches to prevention and management. This research was designed to evaluate whether genotype-guided personalized nutrition counseling produces superior outcomes compared to standard dietary advice in a diverse Asian population [11] . The investigation employed comprehensive genetic profiling, detailed dietary assessment, and longitudinal metabolic monitoring to characterize gene-diet interactions influencing weight management success.

Material and Methods

Material

This randomized controlled trial enrolled 248 overweight and obese adults from the Singapore General Hospital Weight Management Clinic and community recruitment between April 2022 and March 2024. Inclusion criteria comprised age 21-65 years, BMI 25.0-35.0 kg/m², and stable weight (±3 kg) for preceding three months. Exclusion criteria included secondary causes of obesity, current weight loss medication, bariatric surgery history, pregnancy or lactation, and severe chronic disease limiting exercise capacity. The research protocol received approval from the National University of Singapore Institutional Review Board (NUS-IRB-2022-147, approved February 2022). Genetic analysis utilized the Illumina Global Screening Array covering approximately 650,000 variants with additional imputation to reference panels. A focused panel of 47 SNPs selected based on prior association with obesityrelated traits and evidence for gene-diet interactions was extracted for analysis. Blood samples for metabolic assessment were collected following overnight fasting and analyzed for glucose, insulin, lipid profile, and inflammatory markers using standard clinical chemistry methods at the National University Hospital laboratory. Body composition was assessed using dual-energy X-ray absorptiometry (DXA) on Hologic Discovery Wi densitometer.

Methods

Participants were randomized 1:1 to personalized nutrition (PN) or standard care (SC) groups using computergenerated random sequences with stratification by sex and baseline BMI category. The PN group received individualized dietary recommendations incorporating genetic information, with specific guidance for FTO, MC4R, and PPARG genotypes. For example, FTO risk allele carriers received enhanced focus on protein intake and satiety-promoting foods, while PPARG Pro12Ala carriers received recommendations optimized for their insulin sensitivity profile. The SC group received evidence-based dietary counseling following Singapore Health Promotion Board guidelines without genetic information. Both groups attended monthly individual counseling sessions with registered dietitians and received educational materials appropriate to their intervention arm. Dietary intake was assessed using 3-day food records at baseline and months 3 and 6, analyzed using the Singapore Food Composition Database. Physical activity was monitored using accelerometry at corresponding timepoints. Adipose tissue biopsies were obtained from a subset of 60 participants (30 per group) at baseline and month 6 for gene expression analysis using quantitative RT-PCR. Primary outcome was change in BMI from baseline to month 6. Secondary outcomes included changes in body fat percentage, waist circumference, fasting glucose, HOMA-IR, lipid profile, and adipose tissue gene expression. Statistical analysis employed intention-to-treat principles using mixed-effects models with repeated measures. Genediet interactions were assessed through stratified analyses and formal interaction terms. Sample size was calculated to detect 1.5 kg/m² difference in BMI change with 80% power at alpha 0.05, accounting for 15% attrition.

Ethical Considerations

All participants provided written informed consent following comprehensive explanation of research procedures, genetic testing implications, and data confidentiality measures. Genetic counseling was available for participants with concerns regarding test results. Genetic data were stored in encrypted databases with restricted access limited to authorized personnel. Results were returned to participants with appropriate counseling support. The research adhered to the Declaration of Helsinki and Good Clinical Practice guidelines. The personalized nutrition group achieved significantly greater BMI reduction (3.7 ± 1.2 kg/m²) compared to standard care (2.1 ± 0.9 kg/m²) over six months (p< 0.001).

Results

Genotype-stratified analysis revealed differential responses within the personalized group (Figure 1). FTO rs9939609

AA carriers showed the greatest response with mean BMI reduction of 4.2 ± 1.4 kg/m², compared to 3.5 ± 1.1 kg/m² for AT heterozygotes and 2.8 ± 0.9 kg/m² for TT homozygotes (p for trend = 0.003). Metabolic improvements paralleled anthropometric changes, with greater improvements in the personalized nutrition group across all parameters (Figure 2, Table 2). Fasting glucose decreased by 12.4 ± 6.7 mg/dL in the personalized group versus 7.8 ± 5.3 mg/dL in standard care (p< 0.01). HOMA-IR improved by 1.8 ± 0.9 units in the personalized group compared to 1.1 ± 0.7 in controls (p< 0.001).

Comprehensive Interpretation

Gene expression analysis in adipose tissue revealed favorable modulation of metabolic genes in the personalized nutrition group (Figure 4). PPARG expression increased 1.8-fold (p< 0.01), indicating enhanced adipocyte differentiation capacity. ADIPOQ (adiponectin) showed 2.3fold upregulation (p< 0.001), consistent with improved insulin sensitivity. Pro-inflammatory genes IL-6 and TNF-α were downregulated by 50% and 30% respectively (p< 0.001 and p< 0.01). SIRT1, a key metabolic regulator, increased 1.9-fold (p< 0.01), suggesting activation of beneficial metabolic pathways.

Discussion

This randomized controlled trial demonstrates that genotype-guided personalized nutrition counseling produces significantly greater weight loss and metabolic improvement compared to standard dietary advice in an Asian population with overweight and obesity [12][13][14] . The observed differences exceed the threshold considered clinically meaningful and support the utility of incorporating genetic information into dietary intervention design. The differential response according to FTO genotype aligns with biological understanding of this variant's effects on appetite regulation and satiety. The personalized intervention for FTO risk allele carriers emphasized protein intake and low glycemic index foods, strategies known to enhance satiety signaling and potentially counteract the appetite dysregulation associated with this genotype [15] . The magnitude of benefit for AA carriers receiving genotypematched advice was approximately 28% greater than standard intervention, suggesting substantial potential for genetic stratification to optimize outcomes. The improvements in metabolic parameters including fasting glucose, insulin sensitivity, and inflammatory markers exceeded what would be expected from weight loss alone [16] . This suggests that the genotype-guided dietary modifications may exert direct effects on metabolic pathways independent of adiposity changes. The adipose tissue gene expression findings support this interpretation, with upregulation of PPARG and ADIPOQ indicating enhanced metabolic function [17] . The multi-ethnic composition of the Singapore population provides opportunity to examine whether genetic associations established primarily in European populations translate to Asian ancestry groups [18] . The consistent direction and magnitude of gene-diet interactions across ethnic groups in this research supports the generalizability of nutrigenomic approaches, though larger ethnicitystratified analyses would be needed to confirm this preliminary observation [19][20][21] .

Clinical Implications

Acknowledgement

Acknowledgements Funding SourcesThis research was supported by the Singapore Ministry of Health National Medical Research Council and the National University of Singapore Yong Loo Lin School of Medicine. Institutional SupportThe authors acknowledge the Clinical Research Centre at National University Hospital for participant recruitment support and the Genome Institute of Singapore for genotyping services.

References

1. Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. The Lancet. 1902;2:1616-1620.
2. Fenech M, El-Sohemy A, Cahill L, Ferguson LR, French TA, Tai ES, Milner J, Koh WP, Xie L, Zuber M, et al. Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice. Journal of Nutrigenetics and Nutrigenomics. 2011;4(2):69-89.
3. World Health Organization. Obesity and overweight fact sheet. World Health Organization. 2021.
4. Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. British Medical Journal. 2018;361:bmj.k2173.
5. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-894.
6. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.
7. Livingstone KM, Celis-Morales C, Navas-Carretero S, San-Cristobal R, Macready AL, Fallaize R, et al. Effect of an internet-based, personalized nutrition randomized trial on dietary changes associated with the Mediterranean diet. American Journal of Clinical Nutrition. 2016;104(2):288-297.
8. Celis-Morales C, Livingstone KM, Marsaux CF, Forster H, O'Donovan CB, Woolhead C, et al. Design and baseline characteristics of the Food4Me study: a webbased randomised controlled trial of personalised nutrition in seven European countries. Genes and Nutrition. 2015;10(1):450.
9. Nielsen DE, El-Sohemy A. Disclosure of genetic information and change in dietary intake: a randomized controlled trial. PLoS One. 2014;9(11):e112665.
10. Tan LW, Tan AY, Yap CW, Low HB, Goh LG, Fong CW, et al. Preventing childhood obesity in Singapore: a cohort study to optimize engagement. BMC Public Health. 2019;19(1):1057.
11. Grimaldi KA, van Ommen B, Alber A, et al. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes and Nutrition. 2017;12:35.
12. Arkadianos I, Valdes AM, Marber MS, Grinberg RA, et al. Improved weight management using genetic information to personalize a calorie-controlled diet. Nutrition Journal. 2007;6:29.
13. Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR, et al. Sugar-sweetened beverages and genetic risk of obesity. New England Journal of Medicine. 2012;367(15):1387-1396.
14. Huang T, Qi Q, Zheng Y, Ley SH, Manson JE, Hu FB, Qi L. Genetic predisposition to central obesity and risk of type 2 diabetes: two independent cohort studies. Diabetes Care. 2015;38(7):1306-1311.
15. Phillips CM, Kesse-Guyot E, McManus R, Hercberg S, Lairon D, Planells R, Roche HM. High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults. Journal of Nutrition. 2012;142(5):824-831.
16. Martínez-González MA, García-Arellano A, Toledo E, Salas-Salvadó J, Buil-Cosiales P, Corella D, et al. A 14item Mediterranean diet assessment tool and obesity indexes among high-risk subjects. PLoS One. 2012;7(8):e43134.
17. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Pérusse L, Vohl MC. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. American Journal of Clinical Nutrition. 2010;91(2):309-320.
18. Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. European Journal of Clinical Nutrition. 2010;64(1):2-5.
19. Yajnik CS, Yudkin JS. The Y-Y paradox. The Lancet. 2004;363(9403):163.
20. Patel CJ, Chen R, Butte AJ. Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with disease. Bioinformatics. 2012;28(12):i121-i126.
21. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079-1094.